Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer
Clinical trial NCT07235930 · RECRUITING
Trial details
- NCT number
- NCT07235930
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-15
- Primary completion
- 2029-07-01
- Enrollment
- 292
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.